BioRen

BioRen

Antibody discovery and optimization company developing a rational approach to antibody engineering. Bioren utilizes its patented Walk Through Mutagenesis (WTM) technology to design antibodies in an in vitro and fully automated system. Bioren was acquired by Pfizer in August 2005.

< Back to Portfolios